Table 2.
Characteristics of the participants (N=1084) in the web-based survey of health behaviors and Centers for Disease Control and Prevention guideline adherence conducted in June-July 2020.
| Variable | Value | Recode information | |||||
| Age (years), mean (SD) | 40.9 (13.4) | None | |||||
| Sex (assigned at birth), n (%) | We created a combined sex and gender variable recoded to cisgender male if sex=“male” and gender=“man” and no other gender endorsed, cisgender female if sex=“female” and gender=“woman” and no other gender endorsed, and other for all other combinations. | ||||||
|
|
Male | 540 (49.8) |
|
||||
|
|
Female | 536 (49.5) |
|
||||
|
|
Prefer not to answer | 8 (0.7) |
|
||||
| Gender (select all that apply), n (%) | We created a combined sex and gender variable recoded to cisgender male if sex=“male” and gender=“man” and no other gender endorsed, cisgender female if sex=“female” and gender=“woman” and no other gender endorsed, and other for all other combinations. | ||||||
|
|
Man | 529 (48.8) |
|
||||
|
|
Woman | 543 (50.1) |
|
||||
|
|
Nonbinary | 6 (0.6) |
|
||||
|
|
Transgender | 4 (0.4) |
|
||||
|
|
Other or prefer not to answer | 9 (0.8) |
|
||||
| Race (select all that apply), n (%) | We created 4 race categories recoded to White if race=“White” and no other race endorsed, Black or African American if race=“Black or African American” and no other race endorsed, Asian if race=any of “Asian Indian | Chinese | Filipino | Japanese | Korean | Vietnamese | Other Asian” and no other race endorsed; and Other Race or More Than One for all other endorsed categories. | ||||||
|
|
White | 742 (68.5) |
|
||||
|
|
Black or African American | 267 (24.6) |
|
||||
|
|
American Indian or Alaskan Native | 26 (2.4) |
|
||||
|
|
Asian Indian | 34 (3.1) |
|
||||
|
|
Chinese | 31 (2.9) |
|
||||
|
|
Filipino | 6 (0.5) |
|
||||
|
|
Japanese | 3 (0.3) |
|
||||
|
|
Korean | 7 (0.6) |
|
||||
|
|
Vietnamese | 1 (0.1) |
|
||||
|
|
Other Asian | 15 (1.4) |
|
||||
|
|
Native Hawaiian | 2 (0.2) |
|
||||
|
|
Guamanian or Chamorro | 1 (0.1) |
|
||||
|
|
Other Pacific Islander | 5 (0.5) |
|
||||
| Ethnicity (select all that apply), n (%) | We dichotomized ethnicity to Not of Hispanic, Latino/Latina, or Spanish origin, and all other endorsed categories | ||||||
|
|
Not of Hispanic, Latino/Latina, or Spanish Origin | 808 (74.5) |
|
||||
|
|
Mexican, Mexican American, or Chicano/Chicana | 76 (7.0) |
|
||||
|
|
Puerto Rican | 42 (3.9) |
|
||||
|
|
Cuban | 14 (1.3) |
|
||||
|
|
Another Hispanic, Latino/Latina, or Spanish origin | 155 (14.3) |
|
||||
| Education, n (%) | None | ||||||
|
|
College graduate | 547 (50.5) |
|
||||
|
|
Some college | 215 (19.8) |
|
||||
|
|
Professional degree | 215 (19.8) |
|
||||
|
|
High school or lower | 107 (9.9) |
|
||||
| Annual household income, n (%) | Eight ordered categories were treated continuously. | ||||||
|
|
Less than US $25,000 | 123 (11.4) |
|
||||
|
|
US $25,000-$34,999 | 122 (11.3) |
|
||||
|
|
US $35,000-$49,999 | 152 (14.0) |
|
||||
|
|
US $50,000-$74,999 | 287 (26.5) |
|
||||
|
|
US $75,000-$99,999 | 188 (17.3) |
|
||||
|
|
US $100,000-$149,999 | 139 (12.8) |
|
||||
|
|
US $150,000-$199,999 | 39 (3.6) |
|
||||
|
|
US $200,000 and above | 34 (3.1) |
|
||||
| Household size | 3.06 (1.33) | None | |||||
| Dwelling ownership (yes) | 507 (46.8) | None | |||||
| Essential worker, n (%) | Dichotomized to Yes and No or unsure. | ||||||
|
|
No | 641 (59.1) |
|
||||
|
|
Yes | 388 (35.8) |
|
||||
|
|
Unsure | 55 (5.1) |
|
||||
| Centers for Disease Control and Prevention adherence | 2.20 (0.62) | None | |||||
| COVID-19 testing history, n (%) | None | ||||||
|
|
No test or unsure | 805 (74.3) |
|
||||
|
|
Yes | 279 (25.7) |
|
||||
| COVID-19 test result (n=279), n (%) | Either a positive nasal or blood test was recoded as a positive COVID-19 test result. | ||||||
|
|
Negative | 235 (84.2) |
|
||||
|
|
Positive | 44 (15.8) |
|
||||
| Substance use, n (%) | |||||||
|
|
Cigarette use (past 7 days) | Recoded from Timeline Followback | |||||
|
|
|
None | 865 (79.8) |
|
|||
|
|
|
Nondaily (1-6 days) | 66 (6.1) |
|
|||
|
|
|
Daily (7 days) | 153 (14.1) |
|
|||
|
|
Electronic cigarette use (past 7 days), n (%) | Recoded from Timeline Followback | |||||
|
|
|
None | 995 (91.8) |
|
|||
|
|
|
Nondaily (1-6 days) | 39 (3.6) |
|
|||
|
|
|
Daily (7 days) | 50 (4.6) |
|
|||
|
|
Cannabis (past 7 days), n (%) | Recoded from Timeline Followback. Includes use of any form of cannabis | |||||
|
|
|
None | 973 (89.8) |
|
|||
|
|
|
Nondaily (1-6 days) | 49 (4.5) |
|
|||
|
|
|
Daily (7 days) | 62 (5.7) |
|
|||
|
|
Alcohol (past 7 days), n (%) | Recoded from Timeline Followback | |||||
|
|
|
None | 643 (59.3) |
|
|||
|
|
|
Nondaily (1-6 days) | 356 (32.8) |
|
|||
|
|
|
Daily (7 days) | 85 (7.8) |
|
|||
|
|
Opioids (past 7 days), n (%) | Recoded from Timeline Followback. Includes use of any opioids | |||||
|
|
|
None | 858 (79.2) |
|
|||
|
|
|
Nondaily (1-6 days) | 180 (16.6) |
|
|||
|
|
|
Daily (7 days) | 46 (4.2) |
|
|||
|
|
Stimulants (past 7 days), n (%) | Recoded from Timeline Followback | |||||
|
|
|
None | 1015 (93.6) |
|
|||
|
|
|
Nondaily (1-6 days) | 42 (3.9) |
|
|||
|
|
|
Daily (7 days) | 27 (2.5) |
|
|||